Eversept Partners »

Novocure Ltd ord shares owned by Eversept Partners

Quarter-by-quarter ownership of Novocure Ltd ord (NVCR) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Novocure Ltd ord

Tip: Access up to 7 years of quarterly data

All positions including Novocure Ltd ord held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novocure Ltd ord by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 121k 12.93

More positions owned by Eversept Partners

Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
GSK Sponsored Adr (GSK)
United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Miragen Therapeutics (VRDN)
Vaxcyte (PCVX)
Travere Therapeutics (TVTX)
Hca Holdings (HCA)
Danaher Corporation (DHR)
Ionis Pharmaceuticals (IONS)
Celldex Therapeutics Com New (CLDX)
Bruker Corporation (BRKR)

View all positions for Eversept Partners

Top funds holding Novocure Ltd ord

FMR
BlackRock
Vanguard Group
Soleus Capital Management
State Street Corporation
Geode Capital Management
Quantinno Capital Management
Renaissance Technologies
Millennium Management
Nuveen
Palo Alto Investors
Jacobs Levy Equity Management
Goldman Sachs Group
Baillie Gifford & Co
American Century Companies

View all funds holding Novocure Ltd ord